Showing 1 - 1 results of 1 for search 'PRIME Study Group', query time: 0.01s Refine Results
  1. 1
    Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol.

    Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol. by Shinobu Shimizu, Akihito Tanaka, Nao Matsuyama, Fumie Kinoshita, Kazuhiro Furuhashi, Shoichi Maruyama, PRIME Study Group

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: